Delivery Order SPE2DB20D2104-SPE2DB25FNBUJ
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,029.30 by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Risperidone 3 mg tablets in quantities of 60 units. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is expected to be completed by August 18, 2025, with performance taking place at the vendor's corporate office in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,202.26 by the Defense Logistics Agency on August 15, 2025, for the supply of Risperdal 2 mg tablets (60-count packaging). This firm fixed-price, non-set-aside contract has an ultimate completion date of August 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery will be performed at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,169.30 by the Defense Logistics Agency on May 29, 2025, for the supply of Risperidone 0.5 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of May 30, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's ability to meet federal procurement requirements...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperidone 0.5 mg tablets (60-count) with a firm fixed price ceiling value of $6,580.29. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 4, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Risperidone 2 mg tablets in quantities of 60 units at a firm fixed price of $2,213.75. The contract carries an ultimate completion date of July 17, 2025, and represents a non-set-aside, competitively awarded procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for Risperidone 1 mg ODT (orally disintegrating tablet) in unit dose packaging, 30-count quantities. This is a firm fixed-price delivery order with a ceiling value of $1,780.96 and an ultimate completion date of July 22, 2025. The contract is non-set-aside and represents a competitive award. Performance will take place at AmerisourceBergen's corporate office...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for 500 tablets of Risperidone 2 mg at a ceiling value of $3,458. This is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.86 to AmerisourceBergen Drug Corp for 500 tablets of Risperidone 0.25 mg. This contract, issued on June 20, 2025, with an ultimate completion date of June 23, 2025, is a firm fixed price delivery order with no set-aside designation. The award reflects a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, designated as SPE2DX and valued at...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,903.65 from the Defense Logistics Agency (DLA) to supply 60 risperidone 2 mg tablets. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to the DLA Troop Support Medical facility in Conshohocken, Pennsylvania by November 28, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, routinely obtains delivery orders against its indefinite delivery contract with DLA...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $2,118.28 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 500 tablets of the 3 mg dosage of the drug risperidone. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of 3 days from August 4th through August 7th, 2023. The delivery order was issued under DLA's indefinite-delivery/indefinite-quantity...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNBUJDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Risperidone 3 mg tablets (60-count packages) with a ceiling value of $3.07K. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 29, 2025. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9M global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. As a prime contractor under the DLA's Pharmaceutical Prime Vendor Global Program, the company maintains an extensive portfolio of medical product deliveries covering multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The company's demonstrated capability to fulfill diverse federal medical supply requirements through open competition positions it as a key supplier for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 9/26/25 |